Virginia Medical Cannabis Sales Overview – January 2026

Virginia medical cannabis sales January 2026 totaled roughly $15.08 million, according to the new Virginia Cannabis Control Board dashboard. That figure frames a market that has hovered near fifteen million dollars for months.

Flower led demand, while concentrates and edibles also drove patient purchases. However, packaged grams fell compared with prior months, suggesting inventory shifts. There were 126,706 transactions, which shows active patient access across the state. Average price per gram rose to $10.20, reflecting subtle pricing pressure.

Because harvest and packaging volumes dropped, supply dynamics may explain the price movement. In this article we unpack product trends, patient behavior, and regulatory context. Therefore, readers will find data driven insights about plants harvested, grams packaged, and sales mix.

By the end, industry stakeholders should better gauge patient access and near term growth prospects. We also compare these recent metrics with August through December figures to show momentum. Ultimately, this snapshot helps suppliers, clinicians, policymakers, and patient advocates plan next steps.

Virginia medical cannabis sales January 2026: performance and emerging trends

January data shows Virginia medical cannabis sales totaled about $15.08 million. The new Virginia Cannabis Control Board dashboard provides these figures and more. Because the dashboard pulls seed to sale data, the numbers reflect real program activity. Overall, the medical cannabis market Virginia appears steady, however packaging and harvest patterns shifted.

Key takeaways and sales growth trends

• Total sales reached $15.08 million, consistent with recent months and signaling steady patient demand.
• Product mix leaned toward flower at $6.55 million, while concentrates and edibles contributed $5.03 million and $2.55 million respectively.
• Average price per gram rose to $10.20, which may reflect supply constraint or changing consumer mix.
• Packaged grams dropped to 1,216,287, the lowest across the past five months, suggesting inventory tightening.
• There were 126,706 transactions, indicating active usage and broad patient access.
• Harvest activity recorded 7,669 plants in January, bringing the total since August 2025 to 50,624.

For regulatory context and market implications, read related coverage and analysis at regulatory updates. Also see discussion of the adult use sales bill at adult use sales bill discussion. For the dashboard source, visit the medical cannabis dashboard.

Regulatory and market factors affecting Virginia medical cannabis sales January 2026

Virginia cannabis regulations have shaped market access since the program launched. Because the Virginia Cannabis Control Board released a new dashboard, regulators and businesses can now see seed to sale trends. This transparency affects licensing enforcement and compliance oversight.

Key regulatory and market conditions

• Licensing impacts: New dispensary and processor license timelines affect supply. As a result, fewer active licenses can tighten inventory and raise prices.
• Compliance costs: Testing, tracking and reporting requirements increase operational expenses for producers and distributors.
• Patient access: The number of registered patients and transaction counts show steady demand, however limited packaging volumes may reduce available product types.
• Pricing pressure: Average price per gram rose to $10.20 in January, which suggests supply constraints or a shift in product mix.
• Policy signals: Pending adult use legislation and local zoning rules may change market dynamics and investment decisions.

Together these factors explain why sales stayed near $15 million while packaged grams fell. For clearer context, the state dashboard and local reporting provide primary data to guide operators and policymakers.

Notes: Growth is month over month and calculated from the dashboard figures.

CONCLUSION

January 2026 confirmed that Virginia medical cannabis sales held near fifteen million dollars. Flower led the mix, concentrates and edibles remained important, and average price per gram rose to $10.20. However, packaged grams fell sharply, which hints at short term supply pressure and changing inventory flows.

Because licensing timelines and compliance costs shape supply, market conditions January 2026 reflect more than demand. Therefore, operators should watch harvest cycles, packaging volumes, and policy changes closely. Also note EMP0, an emerging market performance indicator that matters for forecasting. As a result, stakeholders can better plan cultivation, distribution, and pricing strategies.

MyCBDAdvisor serves as a full-spectrum, research-driven CBD knowledge source dedicated to clear and reliable cannabinoid information. Visit MyCBDAdvisor for ongoing analysis and resources. For regulatory updates and deeper context, see Cannabis Regulation and Legalization Updates and Virginia Adult Use Cannabis Sales Bill.

Frequently Asked Questions (FAQs)

Bottom line

• Sales held near fifteen million dollars while packaged grams fell
• Patients should check dispensary menus and sign up for restock alerts
• Clinicians should emphasize dosing protocols and COA review